Cargando…
Current Approaches in NSCLC Targeting K-RAS and EGFR
The research and treatment of non-small cell lung cancer (NSCLC) have achieved some important advances in recent years. Nonetheless, the overall survival rates for NSCLC remain low, indicating the importance to effectively develop new therapies and improve current approaches. The understanding of th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888213/ https://www.ncbi.nlm.nih.gov/pubmed/31739412 http://dx.doi.org/10.3390/ijms20225701 |